In Vivo Testing of Drug-Linker Stability-Reference-Cited by-同舟云学术

In Vivo Testing of Drug-Linker Stability

Published:2013 Issue: Volume: Page:101-116
ISSN:1064-3745
Container-title:Methods in Molecular Biology
language:
Short-container-title:

Author:

Abecassis Pierre-Yves,Amara Céline

Publisher

Humana Press

Link

http://link.springer.com/content/pdf/10.1007/978-1-62703-541-5_6

Reference30 articles.

1. Wu AM, Senter PD (2005) Arming antibodies: prospects and challenges for immunoconjugates. Nat Biotechnol 23:1137–1146

2. Lambert JM (2005) Drug-conjugated monoclonal antibodies for the treatment of cancer. Curr Opin Pharmacol 5:543–549

3. Kratz F, Müller IA, Ryppa C, Warnecke A (2008) Prodrug strategies in anticancer chemotherapy. ChemMedChem 3:20–53

4. Mould DR, Sweeney KR (2007) The pharmacokinetics and pharmacodynamics of monoclonal antibodies—mechanistic modeling applied to drug development. Curr Opin Drug Discov Dev 10(1):84–96

5. Carter PJ, Senter PD (2008) Antibody–drug conjugates for cancer therapy. Cancer J 14:154–169

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aminooxy Click Modification of a Periodate-Oxidized Immunoglobulin G: A General Approach to Antibody–Drug Conjugates with Dye-Mediated Expeditious Stoichiometry Control;International Journal of Molecular Sciences;2023-03-07

2. LC-MS characterization of antibody-based therapeutics;Approaches to the Purification, Analysis and Characterization of Antibody-Based Therapeutics;2020

3. Metabolites of Antibody–Maytansinoid Conjugates: Characteristics and in Vitro Potencies;Molecular Pharmaceutics;2015-04-08